These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 6176248)

  • 1. Serum interferon levels in patients with systemic lupus erythematosus.
    Ytterberg SR; Schnitzer TJ
    Arthritis Rheum; 1982 Apr; 25(4):401-6. PubMed ID: 6176248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Circulating interferon in patients with systemic lupus erythematosus. A prospective study].
    Dudli C; Kaiser V; Aguet M; Joller H; Pichler WI; Grob PJ; Fontana A
    Schweiz Med Wochenschr; 1986 Jan; 116(4):104-9. PubMed ID: 2419975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.
    Oke V; Gunnarsson I; Dorschner J; Eketjäll S; Zickert A; Niewold TB; Svenungsson E
    Arthritis Res Ther; 2019 Apr; 21(1):107. PubMed ID: 31036046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of interferons in patients with systemic lupus erythematosus.
    Kim T; Kanayama Y; Negoro N; Okamura M; Takeda T; Inoue T
    Clin Exp Immunol; 1987 Dec; 70(3):562-9. PubMed ID: 2449306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of interferon and anti-interferon in patients with systemic lupus erythematosus.
    von Wussow P; Jakschies D; Hartung K; Deicher H
    Rheumatol Int; 1988; 8(5):225-30. PubMed ID: 3266358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
    Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
    Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.
    Steiman AJ; Gladman DD; Ibañez D; Noamani B; Landolt-Marticorena C; Urowitz MB; Wither JE
    J Rheumatol; 2015 Dec; 42(12):2318-26. PubMed ID: 26568589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher interferon score and normal complement levels may identify a distinct clinical subset in children with systemic lupus erythematosus.
    Tesser A; de Carvalho LM; Sandrin-Garcia P; Pin A; Pastore S; Taddio A; Roberti LR; de Paula Queiroz RG; Ferriani VPL; Crovella S; Tommasini A
    Arthritis Res Ther; 2020 Apr; 22(1):91. PubMed ID: 32334613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
    Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
    PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms.
    Robak E; Sysa-Jedrzejowska A; Robak T; Smolewski P
    Clin Rheumatol; 2006 Mar; 25(2):225-33. PubMed ID: 16432661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type III Interferons in Systemic Lupus Erythematosus: Association Between Interferon λ3, Disease Activity, and Anti-Ro/SSA Antibodies.
    Amezcua-Guerra LM; Márquez-Velasco R; Chávez-Rueda AK; Castillo-Martínez D; Massó F; Páez A; Colín-Fuentes J; Bojalil R
    J Clin Rheumatol; 2017 Oct; 23(7):368-375. PubMed ID: 28937472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peripheral blood mRNA and interferon gene expression in systemic lupus erythematosus].
    Tang JP; Gu YY; Shen N; Qian J; Chen XX; Huang XF; Huang XY; Liang D; Guo Q; Yang CD; Bao CD; Chen SL
    Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):106-10. PubMed ID: 15840221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct stimulation of neutrophil oxygenation activity by serum from patients with systemic lupus erythematosus: a relationship to disease activity.
    Via CS; Allen RC; Welton RC
    J Rheumatol; 1984 Dec; 11(6):745-53. PubMed ID: 6520828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.
    Wirestam L; Enocsson H; Skogh T; Eloranta ML; Rönnblom L; Sjöwall C; Wetterö J
    Clin Exp Immunol; 2017 Jul; 189(1):83-91. PubMed ID: 28257596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between circulating interferon and anti-interferon antibodies and impaired natural killer cell activity in systemic lupus erythematosus.
    Sibbitt WL; Gibbs DL; Kenny C; Bankhurst AD; Searles RP; Ley KD
    Arthritis Rheum; 1985 Jun; 28(6):624-9. PubMed ID: 2408630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological studies on systemic lupus erythematosus.
    Wong W; Lan JL; Wang WC; Fang RC; Chang LC; Chow SJ
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Mar; 13(1):15-26. PubMed ID: 7449519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
    Tripathy R; Panda AK; Das BK
    Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus.
    Doe K; Nozawa K; Hiruma K; Yamada Y; Matsuki Y; Nakano S; Ogasawara M; Nakano H; Ikeda T; Ikegami T; Fujishiro M; Kawasaki M; Ikeda K; Amano H; Morimoto S; Ogawa H; Takamori K; Sekigawa I; Takasaki Y
    Lupus; 2014 Sep; 23(10):1031-41. PubMed ID: 24836587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.